PT  - JOURNAL ARTICLE
AU  - Ito, Tetsuya
AU  - Wang, Da-Qing
AU  - Maru, Morimasa
AU  - Nakajima, Kazuhiro
AU  - Kato, Shiro
AU  - Kurimura, Takashi
AU  - Wakamiya, Nobutaka
TI  - Antitumor Efficacy of Vaccinia Virus-modified Tumor Cell Vaccine
DP  - 1990 Nov 01
TA  - Cancer Research
PG  - 6915--6918
VI  - 50
IP  - 21
4099  - http://cancerres.aacrjournals.org/content/50/21/6915.short
4100  - http://cancerres.aacrjournals.org/content/50/21/6915.full
SO  - Cancer Res1990 Nov 01; 50
AB  - The antitumor efficacies of vaccinia virus-modified tumor cell vaccines were examined in murine syngeneic MH134 and X5563 tumor cells. UV-inactivated vaccinia virus was inoculated i.p. into C3H/HeN mice that had received whole body X-irradiation at 150 rads. After 3 weeks, the vaccines were administered i.p. 3 times at weekly intervals. One week after the last injection, mice were challenged i.p. with various doses of syngeneic MH134 or X5563 viable tumor cells. Four methods were used for preparing tumor cell vaccines: X-ray irradiation; fixation with paraformaldehyde for 1 h or 3 months; and purification of the membrane fraction. All four vaccines were effective, but the former two vaccines were the most effective. A mixture of the membrane fraction of untreated tumor cells and UV-inactivated vaccinia virus also had an antitumor effect. These results indicate that vaccine with the complete cell structure is the most effective. The membrane fraction of UV-inactivated vaccinia virus-absorbed tumor cells was also effective. UV-inactivated vaccinia virus can react with not only intact tumor cells but also the purified membrane fraction of tumor cells and augment antitumor activity. ©1990 American Association for Cancer Research.